Methods and Compositions for Treatment of Epileptic Disorders
Copyright © Targeted News Service 2024
2024-11-19
ALEXANDRIA, Virginia, Nov. 19 -- OVID THERAPEUTICS INC., New York, New York has been assigned a patent (No. US 12144801 B2, initially filed July 13, 2022) developed by Matthew During, Darien, Connecticut, for "Methods and compositions for treatment of epileptic disorders." . . .